Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at SEK 231.1B, ahead of Biogen (SEK 185.8B) and Amgen (SEK 88.1B). Figures as of 20 Nov 2026, 07:46 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesSEK 231.1B
Median
SEK 16.3B
Combined market value
SEK 7.48T
Countries
1

Market values as of .

United States
All sectors
Biotech
SEK
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareSEK 231.1BSEK 2.1TSEK 1,694.85 1.45% down 35% up United States
2BiogenBIIB · Health CareSEK 185.8BSEK 371.8BSEK 2,515.15 1.70% down 49% up United States
3AmgenAMGN · Health CareSEK 88.1BSEK 2.42TSEK 4,466.07 1.14% down 32% up United States
4ModernaMRNA · Health CareSEK 88BSEK 820.8BSEK 2,028.67 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CareSEK 33.1BSEK 161.3BSEK 1,593.69 3.85% down 17% up United States
6VaxcytePCVX · Health CareSEK 27.3BSEK 94BSEK 593.96 0.27% down 23% up United States
7ExelixisEXEL · Health CareSEK 22BSEK 163.5BSEK 669.98 3.60% down 63% up United States
8Bio-TechneTECH · Health CareSEK 21.5BSEK 116.2BSEK 739.90 0.07% down 24% up United States
9RepligenRGEN · Health CareSEK 21.4BSEK 110.8BSEK 1,733.12 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CareSEK 16.6BSEK 351BSEK 1,622.59 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CareSEK 16.1BSEK 103.7BSEK 1,215.09 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CareSEK 12.4BSEK 95.2BSEK 3,214.24 0.15% up 54% up United States
13ImmunovantIMVT · Health CareSEK 8.7BSEK 68.5BSEK 330.97 1.96% down 46% up United States
14CG OncologyCGON · Health CareSEK 7.7BSEK 74.5BSEK 833.53 2.38% up 97% up United States
15Twist BioscienceTWST · Health CareSEK 4.8BSEK 77.5BSEK 1,136.01 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CareSEK 2.5BSEK 62.5BSEK 512.64 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CareSEK 2.2BSEK 46.2BSEK 285.48 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CareSEK 1.6BSEK 65.2BSEK 996.37 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CareSEK 496.8MSEK 108BSEK 946.91 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-SEK 5.1BSEK 71.1BSEK 66.87 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1775 SEK).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (SEK 231.1B), Biogen (SEK 185.8B) and Amgen (SEK 88.1B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 07:46 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of SEK 7.48T as of 20 Nov 2026, 07:46 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.